
|Videos|December 24, 2017 (Updated: December 19, 2020)
Preventing, Treating Relapse After ASCT in Hematologic Malignancy Patients
Author(s)Robert J. Soiffer, MD
This video highlights research into the use of post-transplant therapies to prevent or treat disease recurrence following allogeneic stem cell transplantation.
Advertisement
In this video, Robert J. Soiffer, MD, of the Dana-Farber Cancer Institute in Boston, highlights research into the use of post-transplant therapies to prevent or treat disease recurrence following allogeneic stem cell transplantation (ASCT).
Soiffer gave a presentation on this topic during an education session at the 2017 American Society of Hematology (ASH) Annual Meeting and Exposition, held December 9–12 in Atlanta.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Related Content
Advertisement


Examining TRX103 Tolerance Against Transient Suppression in Mismatched HCT
Published: | Updated:



Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Accepts NDA for Iberdomide Combination in R/R Multiple Myeloma
2
ASCO Issues Updated Guideline for Stage IV NSCLC Therapy
3
First-in-World Trial Explores Subcutaneous Blinatumomab in Rare Leukemia
4
Onvansertib Triplet Improves Efficacy in First-Line RAS-Mutated mCRC
5








































